Septicemia

• FDA approval · 2024-11-19
  FDA Approved: ZOSYN IN GALAXY CONTAINERS — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)

  FDA approved a supplemental application to allow Zosyn in Galaxy containers (piperacillin/tazobactam), a packaging/formulation change from W…

• FDA approval · 2021-04-16
  FDA Approved: AZACTAM — Supplemental Application (E.R. Squibb & Sons, L.L.C.)

  FDA approved a supplemental application for AZACTAM (aztreonam) from E.R. Squibb & Sons, L.L.C. The approval updates the product labeling fo…

• FDA approval · 2016-05-12
  FDA Approved: CLINDAMYCIN PHOSPHATE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)

  FDA approved the supplemental application for clindamycin phosphate (Padagis Israel Pharmaceuticals Ltd), reflecting approval of the supplem…

• FDA approval · 2011-10-26
  FDA Approved: CEFOTETAN — Original Application (Hikma Pharmaceuticals USA Inc.)

  FDA approved the original ANDA for cefotetan from Hikma Pharmaceuticals USA Inc., authorizing a generic cefotetan product.

• FDA approval · 2011-06-30
  FDA Approved: NAFCILLIN — Original Application (Fresenius Kabi USA, LLC)

  FDA approved the original application for Nafcillin sodium (NAFCILLIN SODIUM) as a generic injectable antibiotic from Fresenius Kabi USA, LL…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2010-10-21
  FDA Approved: PIPERACILLIN AND TAZOBACTAM — Original Application (Hospira, Inc)

  FDA approved Hospira's piperacillin/tazobactam combination under an original ANDA application, providing a generic version of the antibiotic…

• FDA approval · 2010-09-20
  FDA Approved: AMPICILLIN AND SULBACTAM — Original Application (Eugia US LLC)

  FDA approved an original ANDA for Ampicillin and Sulbactam by Eugia US LLC, authorizing a generic version of the ampicillin-sulbactam antibi…